Emergent Escherichia coli of the highly virulent B2-ST1193 clone producing KPC-2 carbapenemase in ready-to-eat vegetables [PDF]
: Objectives: Critical priority carbapenem-resistant pathogens constitute a worldwide public health problem. Escherichia coli (E. coli) ST1193 is an emerging high-risk clone that demonstrates prolonged gut persistence, and association with community ...
Karine Dantas +2 more
exaly +7 more sources
Global Phylogeny and F Virulence Plasmid Carriage in Pandemic Escherichia coli ST1193 [PDF]
Lower urinary tract, renal, and bloodstream infections caused by phylogroup B2 extraintestinal pathogenic Escherichia coli (ExPEC) are a leading cause of morbidity and mortality. ST1193 is a phylogroup B2, multidrug-resistant sequence type that has risen
Ethan R Wyrsch +2 more
exaly +8 more sources
Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli [PDF]
Objectives: Sequence type 1193 is emerging as a new, virulent and resistant lineage among fluoroquinolone resistant Escherichia coli (FQrE. coli). In this study, we investigated the prevalence and molecular characteristics of this clone isolated from a ...
Yanfang Lu
exaly +7 more sources
Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain [PDF]
We conducted a prospective, multicenter, specific pilot study on uncomplicated urinary tract infections (uUTI). One-hundred non-duplicated uropathogenic Escherichia coli (UPEC) from uUTI occurred in 2020 in women attending 15 primary care centers of a ...
Isidro García-Meniño +2 more
exaly +7 more sources
Comparative genomic and phenotypic analysis of Escherichia coli ST1193 and ST131 from urinary and bloodstream infections: insights into resistance, virulence, and divergent strategies [PDF]
Background The global dissemination of multidrug-resistant (MDR) Escherichia coli (E. coli) clones, particularly the pandemic ST131 and the emerging ST1193, poses a serious public health threat.
Su Wang, Shuzhen Xiao, Huifang Liu
exaly +5 more sources
Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and High-Risk Escherichia coli CC131, with the First Report of ST1193 as a Causative Agent of Urinary Tract Infections in Human Patients in Algeria [PDF]
Background: High-risk Escherichia coli clones, such as sequence type (ST)131 and ST1193, along with multidrug-resistant (MDR) Klebsiella pneumoniae, are globally recognized for their significant role in urinary tract infections (UTIs).
Hajer Ziadi +5 more
doaj +6 more sources
Escherichia coli ST1193 O75 H5: A rare cause of native valve endocarditis with multifocal emboli to brain and spleen [PDF]
Escherichia coli (E. coli) is a facultative anaerobic gram-negative rod bacterium, which can acquire pathogenicity through the acquisition of additional genetic material. We present a case of E.
John R Lonks, Tao Hong
exaly +6 more sources
Phylogenetic Analysis Reveals Distinct Evolutionary Trajectories of the Fluoroquinolones-Resistant Escherichia coli ST1193 From Fuzhou, China [PDF]
Escherichia coli (E. coli) ST1193 is an emerging fluoroquinolones-resistant and virulent lineage. Large gaps remain in our understanding of the evolutionary processes and differences of this lineage. Therefore, we used 76 E. coli ST1193 genomes to detect
Jiangqing Huang +2 more
exaly +5 more sources
High Rates of Antimicrobial Resistance and Emergence of High-Risk Clones in Community-Acquired Uropathogenic Escherichia coli. [PDF]
A total of 98 E. coli isolates from community‐acquired UTIs were analyzed, revealing high resistance rates to trimethoprim‐sulfamethoxazole and fluoroquinolones. Phylogenetic group B2 was the most prevalent and associated with increased virulence, while ST1193 emerged as the dominant MDR clone.
Galvão VS +5 more
europepmc +2 more sources
Genomic insights into selected multidrug-resistant and ESBL-producing uropathogenic Escherichia coli isolates in central inner Mongolia [PDF]
ObjectiveThe emergence of multidrug-resistant (MDR) and extended-spectrum β-lactamase (ESBL)-producing UPEC has become a global therapeutic challenge. This study aimed to characterize the genomic characteristics, antimicrobial resistance mechanisms, and ...
Jingru Zhang +7 more
doaj +2 more sources

